| Dr Saima Abbas, MD | |
|
1019 Harvin Way Ste 120, Rockledge, FL 32955-3286 | |
| (321) 877-4749 | |
| (321) 877-4751 |
| Full Name | Dr Saima Abbas |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 28 Years |
| Location | 1019 Harvin Way Ste 120, Rockledge, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023272010 | NPI | - | NPPES |
| 001967000 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | ME105482 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Home Health Care Of Florida | Melbourne, FL | Home health agency |
| Steward Rockledge Hospital | Rockledge, FL | Hospital |
| Cape Canaveral Hospital | Cocoa beach, FL | Hospital |
| Viera Hospital | Melbourne, FL | Hospital |
| Parrish Medical Center | Titusville, FL | Hospital |
| Holmes Regional Medical Center | Melbourne, FL | Hospital |
| Entity Name | Abbas & Khans Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952796807 PECOS PAC ID: 7517287717 Enrollment ID: O20150528001866 |
News Archive
ChromoCure, Inc. announced today it executed a Technology Co-Development Agreement with its primary cell preparation and application technology supplier. The co-development agreement calls for the joint-development of a fully integrated chromosomal scanner system for nation-wide distribution to pathology and related cancer detection labs.
Mallinckrodt plc, a leading specialty biopharmaceutical company, and The Gores Group, a global investment firm, announced today that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt will acquire Therakos, Inc. a leading immunotherapy company in a transaction valued at approximately $1.325 billion.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe today announced its financial results for the third quarter ended September 30, 2011 and provided a corporate update. For the quarter, the Company reported net income of $0.3 million or $0.04 per share on a basic and on a fully diluted basis.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced that brentuximab vedotin (SGN-35) will be featured in three poster presentations at the 8th International Symposium on Hodgkin Lymphoma (ISHL) being held October 23-26, 2010 in Cologne, Germany.
Researchers demonstrate today that 70 per cent of protein-coding human genes are related to genes found in the zebrafish and that 84 per cent of genes known to be associated with human disease have a zebrafish counterpart.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Saima Abbas, MD 1019 Harvin Way Ste 120, Rockledge, FL 32955-3286 Ph: (321) 877-4749 | Dr Saima Abbas, MD 1019 Harvin Way Ste 120, Rockledge, FL 32955-3286 Ph: (321) 877-4749 |
News Archive
ChromoCure, Inc. announced today it executed a Technology Co-Development Agreement with its primary cell preparation and application technology supplier. The co-development agreement calls for the joint-development of a fully integrated chromosomal scanner system for nation-wide distribution to pathology and related cancer detection labs.
Mallinckrodt plc, a leading specialty biopharmaceutical company, and The Gores Group, a global investment firm, announced today that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt will acquire Therakos, Inc. a leading immunotherapy company in a transaction valued at approximately $1.325 billion.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe today announced its financial results for the third quarter ended September 30, 2011 and provided a corporate update. For the quarter, the Company reported net income of $0.3 million or $0.04 per share on a basic and on a fully diluted basis.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced that brentuximab vedotin (SGN-35) will be featured in three poster presentations at the 8th International Symposium on Hodgkin Lymphoma (ISHL) being held October 23-26, 2010 in Cologne, Germany.
Researchers demonstrate today that 70 per cent of protein-coding human genes are related to genes found in the zebrafish and that 84 per cent of genes known to be associated with human disease have a zebrafish counterpart.
› Verified 4 days ago
Dr. Jonathan Albert Pinto, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 110 Longwood Ave, Rockledge, FL 32955 Phone: 321-636-2211 | |
Abosede Olatoyosi Adeoshun, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 389 Commerce Pkwy Ste 120, Rockledge, FL 32955 Phone: 321-434-6555 Fax: 321-434-6557 | |
Robert E Barden, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1282 Us Highway 1, Suite 4, Rockledge, FL 32955 Phone: 321-632-4800 Fax: 321-632-6320 | |
Deepika Aneja, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5466 Village Dr Unit C-1, Rockledge, FL 32955 Phone: 321-806-3310 Fax: 321-806-3310 | |
Dr. Vijaykumar C Amin, M.D Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 3322 Siderwheel Dr, Rockledge, FL 32955 Phone: 321-636-0028 Fax: 321-636-0028 | |
German Vergara, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 1295 South Us Higway 1, Rockledge, FL 32955 Phone: 321-637-6654 Fax: 321-433-1119 |